ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันพฤหัสบดีที่ ๕ พฤษภาคม พ.ศ. ๒๕๕๙ ๑๙:๒๕ น.

Food and Healthcare Press Releases

Special Breakthrough Prize In Fundamental Physics Awarded For Detection Of Gravitational Waves 100 Heathcare—๔ พ.ค. ๕๙

Selection Committee of previous Breakthrough Prize winners recognizes contributors to experiment recording waves from two black holes colliding over a billion light years away $3 million prize shared between LIGO founders Ronald W. P. Drever, Kip S.

Mederi To Launch Improved Stretta RFT3 Technology, Highlight New Data at Digestive Disease Week Heathcare—๓ พ.ค. ๕๙

Mederi Therapeutics Inc., manufacturers of Stretta Therapy for gastroesophageal reflux disease (GERD), today announced the launch of RFT3, the third generation of Stretta technology. The new product will be launched at Digestive Disease Week(R) (DDW)

Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring Heathcare—๒๗ เม.ย. ๕๙

POGO is the first glucose meter and multi-test cartridge that combines lancing, sample collection and analysis into easy, one-step testing without the need for separate strips and lancets Intuity Medical, Inc., a privately-held company developing

Reed Sinopharm Hosts World#s Largest Healthcare Event - tHIS in Shanghai Heathcare—๒๒ เม.ย. ๕๙

The Health Industry Summit (tHIS) 2016 opened in Shanghai at the National Exhibition and Convention Center on April 17. The organizer posted a record 380,000 entry scans, 216,784 professional visitors and more than 55,000 exhibiting staff to the venue

Photo Release: Worlds Allergy Specialist Prof. Ralph Mosges Come to Thailand, Lecturing about Heathcare—๒๐ เม.ย. ๕๙

Recently, Mr. Thomas Bursinger, Managing Director, Thailand and Vietnam, of A. Menarini (Thailand) (right) welcomed Professor Ralph Mösges, an otorhinolaryngologist (ear-nose-throat specialist) and allergologist (allergy specialist) and Chairperson

Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Heathcare—๒๐ เม.ย. ๕๙

First published clinical data show prime-boost Ebola vaccine regimen produced an antibody response in 100 percent of healthy volunteers that was sustained 8 months following immunization An Ebola vaccine is still urgently needed to address the problem

Novo Nordisk mark World Haemophilia Day and unveil the 2016 HERO Research Heathcare—๑๘ เม.ย. ๕๙

This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, on World Haemophilia Day, Novo Nordisk announces that the grant scheme to support and encourage research projects focused on

Merck Makes Pioneering Technologies Gavi, Geri and Gems Available to Fertility Heathcare—๑๑ เม.ย. ๕๙

- Merck obtains CE mark certification for consumables of Gavi(TM) and Geri(TM) as well as for the embryo culture media suite Gems(TM) - Geri(TM) now incorporating innovative software module Geri(TM) Connect + Assess, allowing fertility labs enhanced

Official Launch of BookDoc - The Trusted Medical Companion for Tourists Heathcare—๑๑ เม.ย. ๕๙

BookDoc enables better access to healthcare for tourists and supports the medical tourism market with entry into another ASEAN country, Thailand. http://photos.prnasia.com/prnvar/20160409/8521602288 Datuk Seri Mohamed Nazri, Minister of Tourism and

New Anti-histamine to Help Allergic Patients, Innovative Medicine with No Seductive Heathcare—๘ เม.ย. ๕๙

The international medical expert said that the chance of helping allergy patients is increasing after the continuous development of treatment innovation which the new anti-histamine with no seductive potential was found and was able to cure different

Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Heathcare—๗ เม.ย. ๕๙

- Novel liquid biopsy RAS testing now available to clinical practices for metastatic colorectal cancer (mCRC) patients - The test will help guide physicians to select the most effective treatment for mCRC patients in a timely manner Merck, a leading

SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Heathcare—๕ เม.ย. ๕๙

Sirtex (ASX: SRX) announced today that the UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing (MIB)[1] stating that NHS doctors and commissioners may consider SIR-Spheres Y-90 resin microspheres as an

Saxenda(R) demonstrated significant improvements in cardiometabolic risk factors over three years Heathcare—๕ เม.ย. ๕๙

Today, new data from the three-year part of the phase 3a SCALE(TM) (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at the Endocrine Society's 98th Annual Meeting and Expo (ENDO 2016). The three-year

Semaglutide Demonstrated Superior Improvements In Glycaemic Control Vs Placebo In Adults With Type Heathcare—๔ เม.ย. ๕๙

Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide administered once-weekly, significantly improved glycaemic control compared to

Samsung Bioepis# Flixabi(R) Infliximab Biosimilar Recommended for Approval in the European Heathcare—๔ เม.ย. ๕๙

- Samsung Bioepis’ Flixabi(R) receives positive opinion from the Committee for Medicinal Products for Human Use, meets the European Medicines Agency’s requirements on the quality, efficacy and safety of biosimilars - Flixabi(R) becomes the

Victoza(R) (liraglutide 1.8 mg) Provided Superior HbA1c Reductions in Adults with Type 2 Diabetes Heathcare—๔ เม.ย. ๕๙

Findings from a clinical trial comparing Victoza(R) (liraglutide 1.8 mg) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin to Victoza(R) provided superior HbA1c reductions vs continuing with

Taiho#s TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Heathcare—๑ เม.ย. ๕๙

Taiho Pharmaceutical Co., Ltd. of Tokyo announced on April 1 results from its Phase III TERRA study on its oral combination anticancer drug TAS-102 (product name in Japan and the US LONSURF (R), nonproprietary names: trifluridine (FTD) and tipiracil

Janssen to Unveil New Hepatitis B and C Data at The International Liver Congress(TM) 2016 of the Heathcare—๓๑ มี.ค. ๕๙

- Highlights potential of R&D pipeline to deliver several new hepatitis B and C regimens Janssen Sciences Ireland UC and certain Janssen affiliates* today announced it will present thirteen abstracts featuring new data on an investigational regimen

Important Data and Sessions at SAGES 2016 Demonstrate Safety, Efficacy of Stretta Therapy for Heathcare—๓๑ มี.ค. ๕๙

Mederi Therapeutics, Inc. reported that new Stretta data was presented and that Stretta was featured in multiple educational sessions at the recent 2016 Society of American Gastrointestinal and Endoscopic Surgeons ( SAGES ) meeting in Boston. These

Bupa Launches New Viral Clip 5 Minutes Too Late Raising Public Awareness of the Health Heathcare—๒๕ มี.ค. ๕๙

Bupa Thailand has launched a new viral video clip '5 Minutes Too Late…' on its Facebook, YouTube and various social websites to reaffirm of Bupa's commitment to provide a valuable customer experience that support healthy living and deliver its

Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy Heathcare—๒๓ มี.ค. ๕๙

Sirtex (ASX:SRX) announced that the Netherlands Healthcare Institute, Zorginstituut Nederland (ZIN), has agreed to reimburse Selective Internal Radiation Therapy (SIRT) for patients with colorectal liver metastases who have failed on or are intolerant to

Dental Departures Recognizes the World#s Best Dental Clinics with 2016 Global Patients# Choice Heathcare—๒๒ มี.ค. ๕๙

Dental Departures (part of Medical Departures Inc.), one of the leading online dental booking websites for Australians looking to save up to 70% abroad on their dental care, today announces the winners of the 2016 Global Patients' Choice Awards. The

Dental Departures Recognizes the World#s Best Dental Clinics with 2016 Global Patients# Choice Heathcare—๒๒ มี.ค. ๕๙

Dental Departures (part of Medical Departures Inc.), one of the leading online dental booking websites for Canadians looking to save up to 70% abroad on their dental care, today announced the winners of the 2016 Global Patients' Choice Awards. The Global

Medical Departures Secures Series A Investment of USD2.5 million - to Expand Its Medical Service Heathcare—๒๒ มี.ค. ๕๙

Medical Departures, the medical service marketplace that helps patients find, compare and book medical appointments around the globe announces the completion of USD2.5 million Series A financing. Singapore based venture capital fund DMP led the round